|
Volumn 72, Issue 1 SUPPL., 2003, Pages 16-19
|
New therapy update - A unique combination formulation in the treatment of inflammatory acne
a,b c c |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI ACNE AGENT;
BENZOYL PEROXIDE;
CLINDAMYCIN;
ACNE VULGARIS;
ADOLESCENT;
ADULT;
ARTICLE;
BACTERIAL SKIN DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SCREENING;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
RANDOMIZED CONTROLLED TRIAL;
SCHOOL CHILD;
SIDE EFFECT;
SKIN INFLAMMATION;
TREATMENT OUTCOME;
ACNE VULGARIS;
ADMINISTRATION, TOPICAL;
ADOLESCENT;
ADULT;
BENZOYL PEROXIDE;
CLINDAMYCIN;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
FEMALE;
FOLLOW-UP STUDIES;
GELS;
HUMANS;
MALE;
PATIENT SATISFACTION;
PROBABILITY;
REFERENCE VALUES;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
EID: 0141750409
PISSN: 00114162
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (30)
|
References (10)
|